Abstract
Corneal collagen cross-linking (CXL) technique has evolved for more than 10 years and used for ectasia disease as a routine treatment in Europe. It has been proved to be a very effective technique to halt the progression of cornea ectasia diseases as well as a very promising technique for other clinical applications in ophthalmology. Currently the treatment is under the approval by SFDA. Being a nation, extremely lacking of donor corneas, high volume of corneal refractive surgery, sever infective keratitis still being one of the main cause to blindness, we should attach importance to understand CXL technique as well as advocate and promote its clinical application and research. Key words: Corneal collagen cross-linking; Keratoconus; Refractive surgical procedure; Ectasia disease
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
